Hearing loss injection study pulled before it began
NCT ID NCT06437054
First seen May 12, 2026 · Last updated Jun 19, 2026 · Updated 9 times
Summary
This pilot study aimed to test a combination of drugs (dexamethasone, hyaluronic acid, and a green dye) injected into the ear for people with stubborn hearing loss. The goal was to see if the mixture was safe and stayed in the ear long enough to help. However, the study was withdrawn before enrolling any participants, so no data was collected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEARING LOSS, SENSORINEURAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dexamethasone, Hyaluronic acid, and Indocyanine green
What this could lead to
If it had worked, this could have pointed toward a new way to deliver drugs into the ear for stubborn hearing loss.
What could go wrong
This trial was withdrawn before it started, so no results are available. The approach was still very early and unproven.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.